Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott T Tagawa

Showing results (31-40 of 208) with videos related to

Pageof 21
Sort By:
Expert Opinion on Therapeutic Targets|January 31, 2015
Novel molecular targets for urothelial carcinomaBishoy M Faltas, Beerinder S Karir, Scott T Tagawa, et al.
European Urology|May 13, 2026
PSMA-PET Total Tumor Volume Response: Ready for Prime Time or a Work in Progress?Joseph R Osborne, Tobechukwu Joseph Okobi, Valentina Marulanda-Corzo, et al.
Advances in Urology|June 14, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapySatyajit Kosuri, Naveed H Akhtar, Michael Smith, et al.
Oncotargets and Therapy|December 28, 2022
Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab GovitecanMariane S Fontes, Daniel Vargas Pivato de Almeida, Clarissa Cavalin, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 6, 2021
Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot StudyAdithya Balasubramanian, Himanshu Nagar, Christopher E Barbieri, et al.
American Journal of Clinical and Experimental Urology|November 19, 2021
A case report of a patient with plasmacytoid urothelial cancer with significant response to HER2-targeting therapy and enfortumab vedotinMichael Sun, Ariel Schaap, Brian D Robinson, et al.
Expert Opinion on Investigational Drugs|October 9, 2025
Androgen receptor pathway signaling inhibitors in development for prostate cancer therapySara Bleve, Pier Vitale Nuzzo, Abdul Baseet Arham, et al.
Seminars in Nuclear Medicine|November 30, 2010
PET/CT Imaging and Radioimmunotherapy of Prostate CancerKirsten Bouchelouche, Scott T Tagawa, Stanley J Goldsmith, et al.
Urologic Oncology|May 11, 2010
Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancerStephanie Jeske, Scott T Tagawa, Olugbenga Olowokure, et al.
Expert Opinion on Pharmacotherapy|March 4, 2020
An evaluation of the efficacy and safety of erdafitinib for the treatment of bladder cancerJones T Nauseef, Dario M Villamar, Justin Lebenthal, et al.
Pageof 21

Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Expert Opinion on Therapeutic Targets|January 31, 2015
Novel molecular targets for urothelial carcinomaBishoy M Faltas, Beerinder S Karir, Scott T Tagawa, et al.
European Urology|May 13, 2026
PSMA-PET Total Tumor Volume Response: Ready for Prime Time or a Work in Progress?Joseph R Osborne, Tobechukwu Joseph Okobi, Valentina Marulanda-Corzo, et al.
Advances in Urology|June 14, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapySatyajit Kosuri, Naveed H Akhtar, Michael Smith, et al.
Oncotargets and Therapy|December 28, 2022
Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab GovitecanMariane S Fontes, Daniel Vargas Pivato de Almeida, Clarissa Cavalin, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 6, 2021
Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot StudyAdithya Balasubramanian, Himanshu Nagar, Christopher E Barbieri, et al.
American Journal of Clinical and Experimental Urology|November 19, 2021
A case report of a patient with plasmacytoid urothelial cancer with significant response to HER2-targeting therapy and enfortumab vedotinMichael Sun, Ariel Schaap, Brian D Robinson, et al.
Expert Opinion on Investigational Drugs|October 9, 2025
Androgen receptor pathway signaling inhibitors in development for prostate cancer therapySara Bleve, Pier Vitale Nuzzo, Abdul Baseet Arham, et al.
Seminars in Nuclear Medicine|November 30, 2010
PET/CT Imaging and Radioimmunotherapy of Prostate CancerKirsten Bouchelouche, Scott T Tagawa, Stanley J Goldsmith, et al.
Urologic Oncology|May 11, 2010
Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancerStephanie Jeske, Scott T Tagawa, Olugbenga Olowokure, et al.
Expert Opinion on Pharmacotherapy|March 4, 2020
An evaluation of the efficacy and safety of erdafitinib for the treatment of bladder cancerJones T Nauseef, Dario M Villamar, Justin Lebenthal, et al.
Pageof 21